2012: A year unlike any other

SARomics Biostructures is entering 2013 with new owners and with significant new progress in establishing the company on the market as one of the major providers of structural biology and drug discovery services. The year started with our move to the new premises at Medicon Village, the former AstraZeneca site in Lund. The site has been converted to a joint academic-commercial research center with a primary focus on biomedicine. At MV we currently have at our disposal state-of-the-art…

Read More